CRT 2023
Evening Symposium: Individualized Care: What does PCI Optimization Mean in 2023 – Supported Through an Educational Grant by Abbott
Hayder D. Hashim, MD
Interventional Cardiologist
Medstar Washington Hospital Center/Georgetown University
washington, District of Columbia, United States
Disclosure(s): Abbott, Boston Scientific, CSI, Philips: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant Recipient (Ongoing), Speakers' Bureau (Ongoing)
Megha Prasad, MD
Assistant professor
Columbia university
Disclosure(s): Abbott Cardiovascular Systems: Consultant/Advisory Board (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Chiesi: Consultant/Advisory Board (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Conavi: Advisor (Ongoing), Consulting fees or other remuneration (Ongoing)
Bruce Samuels, MD
Interventional cardiologist
Cedars Sinai Medical Center
Beverly Hills, California, United States
Disclosure(s): Philips; Abbott: Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing)
Olga Ivanova Toleva, MD
Associate Professor of Medicine
Emory University
ATLANTA, Georgia, United States
No relationships to disclose
Robert J. Widmer, MD, PhD (he/him/his)
Director Interventional Cath Labs
Baylor Scott & White Health
Belton, Texas, United States
Disclosure(s): Abbot Vascular: Consultant/Advisory Board (Ongoing), Fees for Non-CME Services Received Directly from Commercial Interest or their Agents (e.g., speakers' bureaus) (Ongoing); Philips-Spectranetics: Consultant/Advisory Board (Ongoing)